Abstract
Advanced glycation end products (AGEs) are formed from the non-enzymatic reaction between reducing sugars and amine residues on proteins, lipoproteins or nucleic acids. AGEs are found on long-lived proteins and their tissue accumulation is associated with normal ageing. The formation of AGEs can be accelerated in certain pathological conditions such as diabetes where hyperglycaemia is present. AGE modification of proteins can lead to alterations of normal function by binding to intracellular or extracellular cell components, or through receptor binding. This consequently can initiate a cascade of events, which includes the activation of signal transduction pathways, which activate inflammatory responses causing tissue damage. Such tissue injury contributes to the development of microvascular complications and is of particular relevance in diabetes where interventions to reduce the accumulation of AGEs is desirable.
Keywords: superoxide dismutase, hyperglycaemia, reactive oxygen species, type 2 diabetes, AGE receptors
Protein & Peptide Letters
Title: Advanced Glycation: Implications in Tissue Damage and Disease
Volume: 15 Issue: 4
Author(s): Anna Gasser and Josephine M. Forbes
Affiliation:
Keywords: superoxide dismutase, hyperglycaemia, reactive oxygen species, type 2 diabetes, AGE receptors
Abstract: Advanced glycation end products (AGEs) are formed from the non-enzymatic reaction between reducing sugars and amine residues on proteins, lipoproteins or nucleic acids. AGEs are found on long-lived proteins and their tissue accumulation is associated with normal ageing. The formation of AGEs can be accelerated in certain pathological conditions such as diabetes where hyperglycaemia is present. AGE modification of proteins can lead to alterations of normal function by binding to intracellular or extracellular cell components, or through receptor binding. This consequently can initiate a cascade of events, which includes the activation of signal transduction pathways, which activate inflammatory responses causing tissue damage. Such tissue injury contributes to the development of microvascular complications and is of particular relevance in diabetes where interventions to reduce the accumulation of AGEs is desirable.
Export Options
About this article
Cite this article as:
Gasser Anna and Forbes M. Josephine, Advanced Glycation: Implications in Tissue Damage and Disease, Protein & Peptide Letters 2008; 15 (4) . https://dx.doi.org/10.2174/092986608784246515
DOI https://dx.doi.org/10.2174/092986608784246515 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Ultrasound Therapeutics– A Review
Current Medical Imaging Management of Exercise-induced Glycemic Imbalances in Type 1 Diabetes
Current Diabetes Reviews Curcumin: A Potential Neuroprotective Agent in Parkinson's Disease
Current Pharmaceutical Design Extracellular Proteases as Targets for Drug Development
Current Protein & Peptide Science Tankyrase as a Novel Molecular Target in Cancer and Fibrotic Diseases
Current Drug Targets The Role of AGEs in Cardiovascular Disease
Current Pharmaceutical Design Metabolic Profiling in Disease Diagnosis, Toxicology and Personalized Healthcare
Current Pharmaceutical Biotechnology 12-Lipoxygenase: A Potential Target for Novel Anti-Platelet Therapeutics
Cardiovascular & Hematological Agents in Medicinal Chemistry Genetic Basis of Renal Mass in Rat Models
Current Hypertension Reviews Classical and New Renin-Angiotensin Signalling in Atherosclerosis
Current Signal Transduction Therapy A Brief Review of Cardiovascular Diseases, Associated Risk Factors and Current Treatment Regimes
Current Pharmaceutical Design Protective Effects of Dietary Flavonoids in Diabetic Induced Retinal Neurodegeneration
Current Drug Targets Angiotensin II and the Cardiac Complications of Diabetes Mellitus
Current Pharmaceutical Design Medicinal Chemistry and Pharmacological Effects of Farnesoid X Receptor (FXR) Antagonists
Current Topics in Medicinal Chemistry Carnosine and Diabetic Nephropathy
Current Medicinal Chemistry Soluble RAGE-Modulating Drugs: State-of-the-Art and Future Perspectives for Targeting Vascular Inflammation
Current Vascular Pharmacology Perioperative Considerations in Diabetic Patients
Current Diabetes Reviews Non-dipping Status in Arterial Hypertension: An Overview
Current Vascular Pharmacology Role of Inflammation in Diabetic Nephropathy
Current Diabetes Reviews The Effect of Sex and Gender on Diabetic Complications
Current Diabetes Reviews